52 Week High: $117.39
52 Week Low: $73.71
50 Day MA: $109.11
200 Day MA: $97.43
Low: $73.71
High: $117.39
Low: $116.505
High: $118
As of November 2023, Merck (MRK) has a market cap of $297.8 billion. Our data points out that MRK is ranked #27 in the world. A company's market capitalization is the present value of all of its outstanding shares, and it is commonly used to give a sense of how much the stock of a company would be worth at today's exchange rates. MRK's market cap is -0.706309% down from the last trading day.
Address: 2000 Galloping Hill Road
City: Kenilworth
Zip: 07033
Phone: 908 740 4000
Website: https://www.merck.com
IPO Date: 1978-01-13
CEO: Kenneth C. Frazier
Employees: 67,000
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
